cancer drugs

We can ill afford more of the same from these institutions. The stakes are too high, and the fallout is too great, for the status quo to endure. We deserve justice, not more excuses and more attempts to deprive us of the medicines we have a right to receive.
I don't think that a single day goes by when I don't encounter someone discussing the high cost of cancer drugs. Most often
"This deal is going to end up looking either very smart or very stupid."
This little-known practice is driving up healthcare costs.
According to a new study in JAMA, there is no evidence that the majority of the U.S. Food and Drug Administration-approved cancer drugs over the last five years work.
The fight over prescription drug prices is only just beginning.
What the 21st Century Cures Act ignores is the prevailing, patient agnostic approach to drug development. We need to move toward a patient-centric approach to drug development and approval, and we should start with cancer treatments.
We are in a different time period thanks to scientific discovery. Our health care system and our views of what cancer looks like need to expand to match up with where we are.
The chase was welcomed by investors in both companies, as deal-making grips the healthcare industry. AstraZeneca shares were
"You feel helpless, almost like the world's gone mad," she recalled. "This isn't happening. Surely, in the U.S. and the U.K